{"id":57910,"date":"2024-02-27T18:06:46","date_gmt":"2024-02-27T18:06:46","guid":{"rendered":"https:\/\/medsname.com\/xalatan-eye-drop\/"},"modified":"2026-04-30T10:24:19","modified_gmt":"2026-04-30T10:24:19","slug":"xalatan-eye-drop","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/xalatan-eye-drop\/","title":{"rendered":"Xalatan Eye Drop"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div class=\"medsbase-tldr-answer\" style=\"background:#fffbe6;border-left:4px solid #f5a623;padding:14px 18px;margin:14px 0 22px;border-radius:6px;font-size:15px;line-height:1.55;\">\n<h3 style=\"margin:0 0 6px;font-size:17px;color:#8a6d3b;\">\u26a1 Quick Answer \u2014 What is Xalatan Eye Drop?<\/h3>\n<p style=\"margin:0;\">Xalatan Eye Drop is Latanoprost 0.005%, a once-daily prostaglandin eye drop that lowers eye pressure 25\u201333% in glaucoma. Apply one drop to each affected eye in the evening. Watch for iris darkening and eyelash growth.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f6f7fb;border:1px solid #e3e5ee;border-radius:8px;padding:14px 18px;margin:18px 0;font-size:14px;line-height:1.55;\"><strong style=\"color:#1f3661;\">Pro\u010d objedn\u00e1vat z MedsBase?<\/strong> Dod\u00e1v\u00e1no od v\u00fdrobce certifikovan\u00e9ho WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Doprava po cel\u00e9m sv\u011bt\u011b \u00b7 <a href=\"\/cs\/reviews\/\" rel=\"noopener\">1 400+ ov\u011b\u0159en\u00fdch recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Xalatan Eye Drop is sourced from a WHO-GMP certified manufacturer and shipped worldwide in plain, discreet packaging. Every order is covered by our <a href=\"\/cs\/medsbase-re-shipment-assurance-policy\/\" rel=\"noopener\">Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/a> \u2014 pokud nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me bez dal\u0161\u00edch n\u00e1klad\u016f. Podpo\u0159eno v\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdmi recenzemi z\u00e1kazn\u00edk\u016f.<\/p>\n<h2>What is Xalatan Eye Drop?<\/h2>\n<p>Xalatan Eye Drop is manufactured by Pfizer and contains Latanoprost 0.005% as a sterile ophthalmic solution. Xalatan Eye Drop 0.005% is a prostaglandin F2&alpha; analog used to lower raised intra-ocular pressure (IOP) in open-angle glaucoma and ocular hypertension. It is one of the most potent IOP-lowering eye drops available \u2014 typical reduction is 25\u201333% from baseline. The 3 mL bottle contains benzalkonium chloride preservative \u2014 patients with significant sensitivity should consider preservative-free alternatives. <\/p>\n<h2>Jak funguje Latanoprost<\/h2>\n<p>Latanoprost je syntetick\u00fd strukturn\u00ed analog prostaglandinu F2\u03b1. V\u00e1\u017ee se na FP prostanoidn\u00ed receptor v \u0159asnat\u00e9m t\u011blese, \u010d\u00edm\u017e zvy\u0161uje uveoskler\u00e1ln\u00ed odtok (vedlej\u0161\u00ed dren\u00e1\u017en\u00ed cestu pro komorovou vodu). Proto\u017ee p\u016fsob\u00ed na stran\u011b odtoku sp\u00ed\u0161e ne\u017e na sn\u00ed\u017een\u00ed tvorby komorov\u00e9 vody, je aditivn\u00ed s betablok\u00e1tory, alfa-2 agonisty a inhibitory karboanhydr\u00e1zy. Efekt r\u016fstu \u0159as je zp\u016fsoben aktivac\u00ed FP-receptor\u016f v derm\u00e1ln\u00ed papile vlasov\u00e9ho folikulu \u0159as, co\u017e prodlu\u017euje anagenn\u00ed f\u00e1zi a zesiluje jednotliv\u00e9 vlasov\u00e9 stonky.<\/p>\n<h2>Indikace<\/h2>\n<ul>\n<li><strong>Otev\u0159en\u00fd \u00fahel glaukomu:<\/strong> l\u00e9\u010dba prvn\u00ed volby jako monoterapie u nov\u011b diagnostikovan\u00e9ho prim\u00e1rn\u00edho glaukomu s otev\u0159en\u00fdm \u00fahlem (POAG) podle doporu\u010den\u00e9ho postupu AAO 2020.<\/li>\n<li><strong>O\u010dn\u00ed hypertenze:<\/strong> kdy\u017e je IOP trvale &gt; 21 mmHg s rizikov\u00fdmi faktory (tenk\u00e1 rohovka, rodinn\u00e1 anamn\u00e9za, africk\u00fd nebo hisp\u00e1nsk\u00fd p\u016fvod).<\/li>\n<li><strong>Hypotrich\u00f3za \u0159as<\/strong> (pouze bimatoprost \u2014 indikace Latisse): kosmetick\u00e9 zlep\u0161en\u00ed r\u016fstu \u0159as.<\/li>\n<li><strong>Dopl\u0148kov\u00e1 terapie<\/strong> kdy\u017e l\u00e9\u010dba prvn\u00ed volby nedos\u00e1hne c\u00edlov\u00e9ho nitroo\u010dn\u00edho tlaku \u2014 aditivn\u00ed \u00fa\u010dinek s timololem, brimonidinem, dorzolamidem.<\/li>\n<\/ul>\n<h2>D\u00e1vkov\u00e1n\u00ed a pod\u00e1v\u00e1n\u00ed<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:8px;text-align:left;border:1px solid #ddd;\">Indikace<\/th>\n<th style=\"padding:8px;text-align:left;border:1px solid #ddd;\">D\u00e1vka<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">Prim\u00e1rn\u00ed glaukom s otev\u0159en\u00fdm \u00fahlem \/ o\u010dn\u00ed hypertenze<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">1 kapka do posti\u017een\u00e9ho oka(\u010d\u00ed) jednou denn\u011b, ve\u010der<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ddd;\">Pokud je d\u00e1vka vynech\u00e1na<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Vynechejte a pokra\u010dujte obvykl\u00fdm re\u017eimem n\u00e1sleduj\u00edc\u00ed ve\u010der \u2014 ned\u00e1vejte dvojn\u00e1sobnou d\u00e1vku<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">V\u00edce ne\u017e jedna kapka?<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">P\u0159id\u00e1n\u00ed druh\u00e9 kapky nesni\u017euje nitroo\u010dn\u00ed tlak \u2014 naopak sni\u017euje \u00fa\u010dinnost saturac\u00ed receptor\u016f. P\u0159\u00edsn\u011b jedna kapka do ka\u017ed\u00e9ho oka.<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:8px;border:1px solid #ddd;\">V\u00edce o\u010dn\u00edch kapek<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">Mezi r\u016fzn\u00fdmi o\u010dn\u00edmi kapkami po\u010dkejte alespo\u0148 5 minut, abyste p\u0159ede\u0161li smyt\u00ed \u00fa\u010dinn\u00e9 l\u00e1tky<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:8px;border:1px solid #ddd;\">Kontaktn\u00ed \u010do\u010dky<\/td>\n<td style=\"padding:8px;border:1px solid #ddd;\">P\u0159ed aplikac\u00ed vyjm\u011bte; nasa\u010fte zp\u011bt 15 minut po aplikaci<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Vedlej\u0161\u00ed \u00fa\u010dinky<\/h2>\n<p><strong>\u010cast\u00e9 (5\u201315 %):<\/strong> zarudnut\u00ed o\u010d\u00ed (konjunktiv\u00e1ln\u00ed hyperemie), zes\u00edlen\u00ed\/prodlou\u017een\u00ed\/ztmaven\u00ed \u0159as, sv\u011bd\u011bn\u00ed o\u010d\u00ed, m\u00edrn\u00e9 p\u00e1len\u00ed p\u0159i aplikaci, pocit such\u00e9ho oka.<\/p>\n<p><strong>Kosmeticky v\u00fdznamn\u00e9:<\/strong><\/p>\n<ul>\n<li><strong>Pigmentace duhovky<\/strong> (1\u20132 % b\u011bhem m\u011bs\u00edc\u016f a\u017e let): trval\u00e9 ztmaven\u00ed sv\u011btle zbarven\u00fdch (modr\u00fdch, zelen\u00fdch, o\u0159\u00ed\u0161kov\u00fdch) duhovek stimulac\u00ed melanocyt\u016f stromatu duhovky. Hn\u011bd\u00e9 duhovky obvykle nejsou ovlivn\u011bny. \u0158asy a k\u016f\u017ee v okol\u00ed o\u010d\u00ed mohou tak\u00e9 ztmavnout.<\/li>\n<li><strong>Atrofie periorbit\u00e1ln\u00edho tuku \/ prostaglandinem asociovan\u00e1 periorbitopatie (PAP):<\/strong> prohlouben\u00ed sulku horn\u00edho v\u00ed\u010dka, pt\u00f3za v\u00ed\u010dka, enoftalmus. Nej\u010dast\u011bji hl\u00e1\u0161eno u bimatoprostu &gt; travoprostu &gt; latanoprostu. Obvykle reverzibiln\u00ed 3\u20136 m\u011bs\u00edc\u016f po vysazen\u00ed.<\/li>\n<li><strong>Pigmentace k\u016f\u017ee v okol\u00ed o\u010d\u00ed:<\/strong> reverzibiln\u00ed ztmavnut\u00ed k\u016f\u017ee v\u00ed\u010dek\/okol\u00ed o\u010d\u00ed v d\u016fsledku st\u00e9k\u00e1n\u00ed l\u00e9ku.<\/li>\n<\/ul>\n<p><strong>M\u00e9n\u011b \u010dast\u00e9:<\/strong> cystoidn\u00ed makul\u00e1rn\u00ed ed\u00e9m (CME) \u2013 zejm\u00e9na u pseudofakick\u00fdch o\u010d\u00ed nebo u pacient\u016f s makul\u00e1rn\u00ed patologi\u00ed; reaktivace uveitidy u pacient\u016f s anamn\u00e9zou uveitidy; reaktivace keratitidy zp\u016fsoben\u00e9 virem herpes simplex.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:12px 16px;margin:14px 0;border-radius:4px;font-size:14px;line-height:1.55;\"><strong style=\"color:#a94442;\">Pigmentace duhovky je trval\u00e1.<\/strong> Pacienti s modr\u00fdma, zelen\u00fdma nebo o\u0159\u00ed\u0161kov\u00fdma o\u010dima, kte\u0159\u00ed dlouhodob\u011b u\u017e\u00edvaj\u00ed prostaglandinov\u00fd analog, mohou zaznamenat nevratn\u00e9 ztmavnut\u00ed duhovky (zejm\u00e9na asymetrick\u00e9, pokud je l\u00e9\u010deno pouze jedno oko). Proberte toto riziko p\u0159ed zah\u00e1jen\u00edm l\u00e9\u010dby, pokud je pro v\u00e1s kosmetick\u00fd aspekt d\u016fle\u017eit\u00fd.<\/div>\n<h2>Varov\u00e1n\u00ed a kontraindikace<\/h2>\n<ul>\n<li><strong>Aktivn\u00ed uveitida nebo iritida<\/strong> \u2013 relativn\u00ed kontraindikace; m\u016f\u017ee reaktivovat nitroo\u010dn\u00ed z\u00e1n\u011bt<\/li>\n<li><strong>Pseudofakick\u00e9 o\u010di s poru\u0161enou zadn\u00ed kapsulou, afakie nebo zn\u00e1m\u00e9 riziko makul\u00e1rn\u00edho ed\u00e9mu<\/strong> \u2014 zv\u00fd\u0161en\u00e9 riziko cystoidn\u00edho makul\u00e1rn\u00edho ed\u00e9mu<\/li>\n<li><strong>Aktivn\u00ed herpetick\u00e1 keratitida<\/strong> \u2014 m\u016f\u017ee reaktivovat virov\u00e9 onemocn\u011bn\u00ed<\/li>\n<li><strong>T\u011bhotenstv\u00ed \/ kojen\u00ed<\/strong> \u2014 Kategorie C; vyhn\u011bte se pou\u017eit\u00ed, pokud p\u0159\u00ednos jasn\u011b nep\u0159ev\u00e1\u017e\u00ed riziko (teoretick\u00e1 aktivita d\u011blo\u017en\u00ed hladk\u00e9 svaloviny)<\/li>\n<li><strong>D\u011bti &lt; 16 let<\/strong> \u2014 bezpe\u010dnost pro kosmetick\u00e9 pou\u017eit\u00ed na \u0159asy nebyla stanovena<\/li>\n<\/ul>\n<h2>Skladov\u00e1n\u00ed<\/h2>\n<p>Skladujte p\u0159i pokojov\u00e9 teplot\u011b (15\u201325\u00b0C \/ 59\u201377\u00b0F) mimo p\u0159\u00edm\u00e9 slune\u010dn\u00ed sv\u011btlo. Nesm\u00ed zmrznout. Po prvn\u00edm otev\u0159en\u00ed spot\u0159ebujte do 28 dn\u016f. Uchov\u00e1vejte lahvi\u010dku mezi pou\u017eit\u00edmi pevn\u011b uzav\u0159enou, aby nedo\u0161lo ke kontaminaci.<\/p>\n<p><!-- medsbase-intent-fill-2026-04-29 --><\/p>\n<h2>Xalatan vs generic latanoprost \u2014 should you switch?<\/h2>\n<p>Xalatan is the original branded latanoprost 0.005% from Pfizer (FDA-approved 1996). Generic latanoprost has been available since 2011, manufactured by multiple companies. Both contain the same active ingredient at the same concentration. The clinical question is whether the difference between them justifies the price difference.<\/p>\n<table>\n<thead>\n<tr>\n<th>Vlastnost<\/th>\n<th>Xalatan (Pfizer)<\/th>\n<th>Generic latanoprost<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Active ingredient + concentration<\/td>\n<td>Latanoprost 0.005%<\/td>\n<td>Latanoprost 0.005%<\/td>\n<\/tr>\n<tr>\n<td>IOP reduction (clinical trials)<\/td>\n<td>25\u201333%<\/td>\n<td>25\u201333% (FDA bioequivalence)<\/td>\n<\/tr>\n<tr>\n<td>Preservative<\/td>\n<td>Benzalkonium chloride (BAK) 0.02%<\/td>\n<td>Usually BAK; some preservative-free generics available<\/td>\n<\/tr>\n<tr>\n<td>Refrigeration before opening<\/td>\n<td>Yes (2\u20138 \u00b0C)<\/td>\n<td>Most generics: yes; some require ambient<\/td>\n<\/tr>\n<tr>\n<td>Stability after opening<\/td>\n<td>4 weeks at room temperature<\/td>\n<td>4 weeks at room temperature<\/td>\n<\/tr>\n<tr>\n<td>Cost per 2.5 ml bottle<\/td>\n<td>Higher (branded)<\/td>\n<td>~30\u201360% lower<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Most patients can switch from Xalatan to generic latanoprost without losing IOP control. The main exception is patients who developed BAK-related ocular surface disease on Xalatan and need a preservative-free formulation \u2014 those are limited to specific generics (Monoprost, Lacoma PF) or need to switch to a different prostaglandin.<\/p>\n<h2>Xalatan vs other prostaglandin eye drops<\/h2>\n<table>\n<thead>\n<tr>\n<th>Drop<\/th>\n<th>Active<\/th>\n<th>IOP reduction<\/th>\n<th>Iris pigmentation risk<\/th>\n<th>Periorbital fat atrophy (PAP)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong>Xalatan \/ latanoprost<\/strong><\/td>\n<td>Latanoprost 0.005%<\/td>\n<td>25\u201333%<\/td>\n<td>Significant in light-hued eyes<\/td>\n<td>Less than bimatoprost<\/td>\n<\/tr>\n<tr>\n<td><a href=\"\/cs\/lumigan-eye-drop\/\">Lumigan \/ bimatoprost<\/a><\/td>\n<td>Bimatoprost 0.01% \/ 0.03%<\/td>\n<td>30\u201335% (the strongest IOP reducer of the class)<\/td>\n<td>Significant<\/td>\n<td>Most reported with this molecule<\/td>\n<\/tr>\n<tr>\n<td><a href=\"\/cs\/travatan-eye-drop\/\">Travatan \/ travoprost<\/a><\/td>\n<td>Travoprost 0.004%<\/td>\n<td>27\u201332%<\/td>\n<td>Significant<\/td>\n<td>Reported<\/td>\n<\/tr>\n<tr>\n<td><a href=\"\/cs\/lacoma-pf-eye-drop\/\">Lacoma PF<\/a><\/td>\n<td>Latanoprost 0.005% (preservative-free)<\/td>\n<td>25\u201333%<\/td>\n<td>Same as Xalatan<\/td>\n<td>Same<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3>What about Xalatan and lash growth?<\/h3>\n<p>Latanoprost was the first prostaglandin shown to thicken, lengthen and darken eyelashes \u2014 an unintended cosmetic effect that led directly to the development of the bimatoprost-based <a href=\"\/cs\/careprost-eye-drops\/\">Careprost \/ Latisse<\/a> for lash hypotrichosis. With Xalatan, lashes typically thicken over 3\u20136 months and revert when the drop is stopped. This effect is harmless when expected \u2014 but periocular skin can also darken slightly, which is harder to reverse.<\/p>\n<h3>What does Xalatan cost vs generics?<\/h3>\n<p>Branded Xalatan from Pfizer carries a premium of roughly 2\u20133\u00d7 over generic latanoprost. We supply both \u2014 the WHO-GMP certified generic latanoprost is the same molecule at the same concentration with documented bioequivalence. See the <a href=\"\/cs\/eye-care\/\">Eye Care category<\/a> for the full prostaglandin family.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3>How long until I see results from Xalatan Eye Drop?<\/h3>\n<p>U glaukomu za\u010d\u00edn\u00e1 sn\u00ed\u017een\u00ed nitroo\u010dn\u00edho tlaku do 4 hodin po prvn\u00ed d\u00e1vce s maxim\u00e1ln\u00edm \u00fa\u010dinkem za 8\u201312 hodin; stabiln\u00ed nitroo\u010dn\u00ed tlak je dosa\u017een za 4 t\u00fddny. Pro r\u016fst \u0159as (bimatoprost) je viditeln\u00e9 zahu\u0161t\u011bn\u00ed patrn\u00e9 za 4 t\u00fddny a pln\u00fd r\u016fst \u0159as za 16 t\u00fddn\u016f.<\/p>\n<h3>Co kdy\u017e zapomenu d\u00e1vku?<\/h3>\n<p>Vynechejte vynechanou d\u00e1vku a pokra\u010dujte v obvykl\u00e9m jednou denn\u00edm ve\u010dern\u00edm re\u017eimu. Ned\u00e1vejte dvojn\u00e1sobnou d\u00e1vku \u2013 pou\u017eit\u00ed dvou kapek najednou ve skute\u010dnosti sni\u017euje \u00fa\u010dinnost kv\u016fli saturaci receptor\u016f.<\/p>\n<h3>Pro\u010d Latanoprost tmav\u00ed barvu o\u010d\u00ed?<\/h3>\n<p>Latanoprost aktivuje FP prostanoidn\u00ed receptor na melanocytech stromatu duhovky, \u010d\u00edm\u017e stimuluje produkci melaninu. Sv\u011btlej\u0161\u00ed duhovky (modr\u00e9, zelen\u00e9, o\u0159\u00ed\u0161kov\u00e9) obsahuj\u00ed m\u00e9n\u011b z\u00e1kladn\u00edho melaninu, a proto zm\u011bnu vykazuj\u00ed sn\u00e1ze. Tento efekt je trval\u00fd a m\u016f\u017ee b\u00fdt asymetrick\u00fd, pokud je l\u00e9\u010den\u00e9 pouze jedno oko.<\/p>\n<h3>Can I use Xalatan Eye Drop if I wear contact lenses?<\/h3>\n<p>Ano, ale p\u0159ed aplikac\u00ed odstra\u0148te kontaktn\u00ed \u010do\u010dky a po\u010dkejte 15 minut p\u0159ed jejich op\u011btovn\u00fdm nasazen\u00edm. Konzerva\u010dn\u00ed l\u00e1tka benzalkoniumchlorid m\u016f\u017ee b\u00fdt absorbov\u00e1na m\u011bkk\u00fdmi \u010do\u010dkami a zp\u016fsobit podr\u00e1\u017ed\u011bn\u00ed.<\/p>\n<h3>Is Xalatan Eye Drop safe in pregnancy?<\/h3>\n<p>Kategorie C. Teoretick\u00e9 obavy t\u00fdkaj\u00edc\u00ed se \u00fa\u010dink\u016f prostaglandin\u016f na hladk\u00e9 svalstvo d\u011blohy. Proberte se sv\u00fdm oftalmologem \u2013 v\u011bt\u0161ina klinik\u016f b\u011bhem t\u011bhotenstv\u00ed p\u0159ech\u00e1z\u00ed na beta-blok\u00e1tor nebo brimonidin, nebo zcela p\u0159eru\u0161\u00ed kosmetick\u00e9 pou\u017e\u00edv\u00e1n\u00ed \u0159as.<\/p>\n<h3>What happens if I stop using Xalatan Eye Drop?<\/h3>\n<p>U glaukomu se nitroo\u010dn\u00ed tlak vr\u00e1t\u00ed na v\u00fdchoz\u00ed hodnotu do 4 t\u00fddn\u016f po vysazen\u00ed. Pro kosmetick\u00e9 pou\u017eit\u00ed \u0159as se \u0159asy vr\u00e1t\u00ed na svou p\u016fvodn\u00ed d\u00e9lku a hustost 4\u20138 t\u00fddn\u016f po vysazen\u00ed. Ztmavnut\u00ed duhovky je v\u0161ak trval\u00e9.<\/p>\n<h3>Can I use Xalatan Eye Drop on my lower lashes?<\/h3>\n<p>Ne. Produkt je schv\u00e1len pouze pro aplikaci na horn\u00ed \u0159asovou linii. Aplikace na spodn\u00ed \u0159asy zp\u016fsobuje nadm\u011brn\u00fd odtok na tv\u00e1\u0159, co\u017e zvy\u0161uje riziko ne\u017e\u00e1douc\u00edho r\u016fstu chloupk\u016f na k\u016f\u017ei a zm\u011bn pigmentace k\u016f\u017ee.<\/p>\n<h3>Does Xalatan Eye Drop cause periorbital changes?<\/h3>\n<p>Ano \u2013 prostaglandinem asociovan\u00e1 periorbitopatie (PAP) popisuje syndrom prohlouben\u00e9ho sulku horn\u00edho v\u00ed\u010dka, pt\u00f3zy a enoftalmu pozorovan\u00fd u 5\u201325 % dlouhodob\u00fdch u\u017eivatel\u016f. Bimatoprost m\u00e1 nejvy\u0161\u0161\u00ed hl\u00e1\u0161enou m\u00edru; latanoprost nejni\u017e\u0161\u00ed. Obvykle reverzibiln\u00ed 3\u20136 m\u011bs\u00edc\u016f po vysazen\u00ed.<\/p>\n<h3>Can Xalatan Eye Drop be combined with other glaucoma drops?<\/h3>\n<p>Ano \u2014 analogy prostaglandin\u016f jsou aditivn\u00ed s betablok\u00e1tory, agonisty alfa-2 a inhibitory karboanhydr\u00e1zy, proto\u017ee p\u016fsob\u00ed na odtokovou stranu. Mezi r\u016fzn\u00fdmi kapkami vy\u010dkejte 5 minut. Pro lep\u0161\u00ed adherenci existuj\u00ed fixn\u00ed kombinace jako bimatoprost+timolol.<\/p>\n<h3>Jak\u00fd je rozd\u00edl mezi latanoprostem a dal\u0161\u00edmi prostaglandiny?<\/h3>\n<p>V\u0161echny t\u0159i (latanoprost, travoprost, bimatoprost) sni\u017euj\u00ed nitroo\u010dn\u00ed tlak o 25\u201333 %. Latanoprost m\u00e1 nejm\u00edrn\u011bj\u0161\u00ed profil vedlej\u0161\u00edch \u00fa\u010dink\u016f. Travoprost m\u00e1 m\u00edrn\u011b vy\u0161\u0161\u00ed m\u00edru odpov\u011bdi. Bimatoprost je nej\u00fa\u010dinn\u011bj\u0161\u00ed jak pro sn\u00ed\u017een\u00ed nitroo\u010dn\u00edho tlaku, tak pro r\u016fst \u0159as, ale s nejvy\u0161\u0161\u00ed m\u00edrou konjunktiv\u00e1ln\u00ed hyper\u00e9mie a PAP.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3>Dal\u0161\u00ed o\u010dn\u00ed l\u00e9ky<\/h3>\n<p>Z\u00e1kazn\u00edci, kte\u0159\u00ed si prohl\u00ed\u017eej\u00ed tento produkt, tak\u00e9 zva\u017euj\u00ed tyto alternativy v na\u0161\u00ed <a href=\"\/cs\/eye-care\/\">P\u00e9\u010de o o\u010di<\/a> nab\u00eddce:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/xalatan-eye-drop\/\">Xalatan o\u010dn\u00ed kapky (latanoprost)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/azopt-eye-drops\/\">Azopt o\u010dn\u00ed kapky (brinzolamid)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/alphagan-p-drop\/\">Alphagan P kapky (brimonidin)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/iotim-eye-drops\/\">Iotim o\u010dn\u00ed kapky (timolol)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/careprost-eye-drops\/\">Careprost (bimatoprost)<\/a><\/li>\n<\/ul>\n<h3>L\u00e9ka\u0159sk\u00e9 upozorn\u011bn\u00ed<\/h3>\n<p style=\"font-size:13px;color:#555;\">Informace na t\u00e9to str\u00e1nce slou\u017e\u00ed pouze pro vzd\u011bl\u00e1vac\u00ed \u00fa\u010dely a nenahrazuj\u00ed l\u00e9ka\u0159skou pomoc kvalifikovan\u00e9ho oftalmologa nebo optometristy. O\u010dn\u00ed onemocn\u011bn\u00ed mohou rychle ohrozit zrak \u2014 n\u00e1hl\u00e1 ztr\u00e1ta zraku, siln\u00e1 bolest nebo trauma p\u0159edstavuj\u00ed oftalmologickou pohotovost. P\u0159ed zah\u00e1jen\u00edm, ukon\u010den\u00edm nebo zm\u011bnou jak\u00e9koli l\u00e9\u010dby se v\u017edy pora\u010fte s odborn\u00edkem na p\u00e9\u010di o zrak.<\/p>","protected":false},"excerpt":{"rendered":"<p>Xalatan (latanoprost 0.005%) \u2014 Pfizer original prostaglandin analogue. Once-daily eye drop, first-line IOP lowering for open-angle glaucoma. Bedtime instillation.<\/p>","protected":false},"featured_media":57911,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3343,3342],"product_tag":[4381,4382,4383],"class_list":{"0":"post-57910","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-eye-care","8":"product_cat-general-health","9":"product_tag-latanoprost","10":"product_tag-xalatan","11":"product_tag-xalatan-eye-drop","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/57910","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=57910"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/57911"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=57910"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=57910"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=57910"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=57910"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}